• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将临床特征纳入多变量逻辑回归模型以鉴别诊断TI-RADS 4类甲状腺结节的良恶性。

Incorporation of clinical features into a multivariate logistic regression model for the differential diagnosis of benign and malignant TI-RADS 4 thyroid nodules.

作者信息

Hu Jun, Du Xian, Jiang Yongbin, Wang Yunle, Yang Lijuan

机构信息

Health Examination Center, Shanghai Health and Medical Center (Huadong Sanatorium), Wuxi, China.

出版信息

Front Endocrinol (Lausanne). 2025 May 29;16:1550034. doi: 10.3389/fendo.2025.1550034. eCollection 2025.

DOI:10.3389/fendo.2025.1550034
PMID:40510463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12158692/
Abstract

OBJECTIVE

This study aimed to explore the diagnostic value of clinical features in the assessment of malignant thyroid Imaging Reporting and Data System (TIRADS) category 4 thyroid nodules and to provide a more effective reference for clinical diagnostic practices.

METHODS

A total of 998 patients with 1,103 TIRADS 4 thyroid nodules underwent conventional ultrasound (US) and clinical information assessment at the Shanghai Health and Medical Center from January 1, 2012, to June 30, 2024. A qualitative assessment of clinical and US features was performed, followed by univariable and multivariable logistic regression analyses using a training cohort, which contributed to the construction of the clinical TIRADS model. A receiver-operating characteristic (ROC) curve, a Hosmer-Lemeshow (HL) test and a decision curve analysis (DCA) were employed to further validate this model in the validation cohort.

RESULTS

Patient age, body mass index, sex, family history of thyroid carcinoma, and US features-such as vertical orientation, ill-defined or irregular margins or extrathyroidal extensions, microcalcifications, blood flow signals of central or peripheral vessels, and swollen cervical lymph nodes-were identified as independent risk factors in the clinical scoring model for TI-RADS 4 nodules. This diagnostic model achieved an area under the curve (AUC) of 0.943 [0.928, 0.959], with a sensitivity of 82.33%, specificity of 94.44%, diagnostic threshold of 5 points, accuracy of 87.42%, positive predictive value of 95.34%, and negative predictive value of 79.48% in the validation cohort. The HL tests and DCA also demonstrated excellent predictive performances.

CONCLUSIONS

The integration of clinical and US features in the construction of the diagnostic model can significantly enhance the diagnosis of TIRADS 4 thyroid nodules and provide a reliable evaluation tool for clinical practice.

摘要

目的

本研究旨在探讨临床特征在评估甲状腺影像报告和数据系统(TIRADS)4类甲状腺结节中的诊断价值,为临床诊断实践提供更有效的参考。

方法

2012年1月1日至2024年6月30日,共有998例患有1103个TIRADS 4类甲状腺结节的患者在上海健康与医学中心接受了常规超声(US)检查和临床信息评估。对临床和超声特征进行了定性评估,随后使用训练队列进行单变量和多变量逻辑回归分析,这有助于构建临床TIRADS模型。采用受试者操作特征(ROC)曲线、Hosmer-Lemeshow(HL)检验和决策曲线分析(DCA)在验证队列中进一步验证该模型。

结果

患者年龄、体重指数、性别、甲状腺癌家族史以及超声特征,如垂直方向、边界不清或不规则、甲状腺外侵犯、微钙化、中央或外周血管血流信号以及颈部淋巴结肿大,被确定为TI-RADS 4类结节临床评分模型中的独立危险因素。该诊断模型在验证队列中的曲线下面积(AUC)为0.943[0.928, 0.959],灵敏度为82.33%,特异度为94.44%,诊断阈值为5分,准确率为87.42%,阳性预测值为95.34%,阴性预测值为79.48%。HL检验和DCA也显示出优异的预测性能。

结论

在诊断模型构建中整合临床和超声特征可显著提高TIRADS 4类甲状腺结节的诊断水平,并为临床实践提供可靠的评估工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/12158692/439477d2eca7/fendo-16-1550034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/12158692/0e8c7166d1fb/fendo-16-1550034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/12158692/97dfa7d41bf8/fendo-16-1550034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/12158692/439477d2eca7/fendo-16-1550034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/12158692/0e8c7166d1fb/fendo-16-1550034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/12158692/97dfa7d41bf8/fendo-16-1550034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bc5/12158692/439477d2eca7/fendo-16-1550034-g003.jpg

相似文献

1
Incorporation of clinical features into a multivariate logistic regression model for the differential diagnosis of benign and malignant TI-RADS 4 thyroid nodules.将临床特征纳入多变量逻辑回归模型以鉴别诊断TI-RADS 4类甲状腺结节的良恶性。
Front Endocrinol (Lausanne). 2025 May 29;16:1550034. doi: 10.3389/fendo.2025.1550034. eCollection 2025.
2
Diagnostic efficacy of CEUS TI-RADS classification for benign and malignant thyroid nodules.CEUS TI-RADS分类对甲状腺良恶性结节的诊断效能
Clin Hemorheol Microcirc. 2025;89(1):27-41. doi: 10.3233/CH-232080.
3
Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study.超声造影及TI-RADS分类对甲状腺良恶性肿瘤的临床诊断价值:一项队列对比研究。
Medicine (Baltimore). 2019 Jan;98(4):e14051. doi: 10.1097/MD.0000000000014051.
4
Discriminating Malignancy in Thyroid Nodules: The Nomogram Versus the Kwak and ACR TI-RADS.鉴别甲状腺结节的恶性程度:列线图与夸克和美国放射学会甲状腺影像报告和数据系统的比较
Otolaryngol Head Neck Surg. 2020 Dec;163(6):1156-1165. doi: 10.1177/0194599820939071. Epub 2020 Jul 21.
5
Comparison among TIRADS (ACR TI-RADS and KWAK- TI-RADS) and 2015 ATA Guidelines in the diagnostic efficiency of thyroid nodules.比较 TIRADS(ACR TI-RADS 和 KWAK-TI-RADS)与 2015 年 ATA 指南在甲状腺结节诊断效率中的应用。
Endocrine. 2019 Apr;64(1):90-96. doi: 10.1007/s12020-019-01843-x. Epub 2019 Jan 18.
6
Assessment of the American College of Radiology Thyroid Imaging Reporting and Data System for Thyroid Nodule Malignancy Risk Stratification in a Pediatric Population.评估美国放射学院甲状腺影像报告和数据系统在儿科人群中甲状腺结节恶性风险分层的应用。
AJR Am J Roentgenol. 2019 Jan;212(1):188-194. doi: 10.2214/AJR.18.20099. Epub 2018 Nov 7.
7
A Clinical Retrospective Study on the Qualitative Value of Multimodal Ultrasonography for ACR-TIRADS 4 Thyroid Nodules Ranging from 1 cm to 1.5 cm.1cm 至 1.5cm 之间 ACR-TIRADS4 甲状腺结节的多模态超声定性价值的临床回顾性研究
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241297599. doi: 10.1177/15330338241297599.
8
Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules.S-Detect 与甲状腺影像报告和数据系统分类在诊断细胞学不确定的甲状腺结节中的比较。
Front Endocrinol (Lausanne). 2023 Jan 24;14:1098031. doi: 10.3389/fendo.2023.1098031. eCollection 2023.
9
Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Various Pathological Types.ACR-TIRADS 评分对不同病理类型甲状腺良恶性结节的诊断效率。
Med Sci Monit. 2024 May 20;30:e943228. doi: 10.12659/MSM.943228.
10
Diagnostic value of multimodal ultrasound imaging in differentiating benign and malignant TI-RADS category 4 nodules.多模态超声成像在鉴别 TI-RADS 4 类良恶性结节中的诊断价值。
Int J Clin Oncol. 2019 Jun;24(6):632-639. doi: 10.1007/s10147-019-01397-y. Epub 2019 Mar 1.

本文引用的文献

1
Author Correction: ThyroNet-X4 genesis: an advanced deep learning model for auxiliary diagnosis of thyroid nodules' malignancy.作者更正:ThyroNet-X4起源:一种用于辅助诊断甲状腺结节恶性肿瘤的先进深度学习模型。
Sci Rep. 2025 Mar 27;15(1):10599. doi: 10.1038/s41598-025-94090-2.
2
Exploration of the Evaluation Value of Combined Magnetic Resonance Imaging and Ultrasound Blood Flow Parameters in Cervical Lymph Node Metastasis of Thyroid Cancer.磁共振成像与超声血流参数联合评估在甲状腺癌颈淋巴结转移中的价值探讨
Cancer Manag Res. 2025 Mar 20;17:651-659. doi: 10.2147/CMAR.S505730. eCollection 2025.
3
Machine Learning Model for Risk Stratification of Papillary Thyroid Carcinoma Based on Radiopathomics.
基于放射组学的甲状腺乳头状癌风险分层机器学习模型
Acad Radiol. 2025 May;32(5):2545-2553. doi: 10.1016/j.acra.2024.12.062. Epub 2025 Jan 26.
4
Development of machine learning models to predict papillary carcinoma in thyroid nodules: The role of immunological, radiologic, cytologic and radiomic features.用于预测甲状腺结节中乳头状癌的机器学习模型的开发:免疫学、放射学、细胞学和放射组学特征的作用。
Auris Nasus Larynx. 2024 Dec;51(6):922-928. doi: 10.1016/j.anl.2024.09.002. Epub 2024 Sep 20.
5
Diagnostic Nomogram Model for ACR TI-RADS 4 Nodules Based on Clinical, Biochemical Data and Sonographic Patterns.基于临床、生化数据及超声特征的ACR TI-RADS 4类结节诊断列线图模型
Clin Endocrinol (Oxf). 2025 Jan;102(1):79-90. doi: 10.1111/cen.15130. Epub 2024 Sep 16.
6
Defining angioinvasion and lymphatic invasion in papillary thyroid carcinoma: morphological criteria, utility of D2-40/CD31/ERG immunohistochemistry and correlation with clinicopathological characteristics.定义甲状腺乳头状癌的血管侵犯和淋巴管侵犯:形态学标准、D2-40/CD31/ERG 免疫组化的应用及与临床病理特征的相关性。
Histopathology. 2024 Dec;85(6):950-958. doi: 10.1111/his.15285. Epub 2024 Jul 18.
7
Combining TSH measurement with TIRADS assessment to further improve the detection of thyroid cancers.将 TSH 测量与 TIRADS 评估相结合,以进一步提高甲状腺癌的检出率。
Minerva Endocrinol (Torino). 2024 Jun;49(2):125-131. doi: 10.23736/S2724-6507.24.04207-6.
8
Utilizing machine learning for early screening of thyroid nodules: a dual-center cross-sectional study in China.利用机器学习进行甲状腺结节的早期筛查:中国的一项双中心横断面研究。
Front Endocrinol (Lausanne). 2024 Jun 14;15:1385167. doi: 10.3389/fendo.2024.1385167. eCollection 2024.
9
Comparison of the C-TIRADS, ACR-TIRADS, and ATA guidelines in malignancy risk stratification of thyroid nodules.C-TIRADS、ACR-TIRADS和ATA指南在甲状腺结节恶性风险分层中的比较。
Quant Imaging Med Surg. 2023 Jul 1;13(7):4514-4525. doi: 10.21037/qims-22-826. Epub 2023 May 15.
10
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.2023 年欧洲甲状腺协会甲状腺结节管理临床实践指南。
Eur Thyroid J. 2023 Aug 14;12(5). doi: 10.1530/ETJ-23-0067. Print 2023 Oct 1.